About The Position

Pfizer Commercial Oncology is seeking a senior commercial leader to oversee its US breast cancer CDK4/6 portfolio. The role owns the IBRANCE P&L and atirmociclib’s pre-launch investment plan, balancing IBRANCE’s value through its PATINA launch, 10-year heritage campaign, IRA impact and loss of exclusivity with the preparation of atirmociclib for future launches. The successful candidate will set a multi-year portfolio strategy, make resource and investment trade-offs, and influence senior leaders across Pfizer. The position leads 6–8 HCP and patient marketers at Director and Senior Manager levels. It is accountable for IBRANCE forecasting, operating expenses, resource allocation and revenue and expense trade-offs, as well as atirmociclib launch readiness, market shaping, evidence planning, customer strategy and investment decisions. The leader will coordinate with functions including Market Access, Pricing, Trade, Medical Affairs, Clinical Development, Global, Commercial Insights, Analytics and Sales. The role also leads an integrated patient and advocacy strategy, connecting patient experience, support and adherence programs with commercial outcomes. It will guide the transition of customers, accounts and field effort from IBRANCE to atirmociclib, while collaborating with other franchise asset teams. The position reports to the VP, US Breast Cancer Franchise Lead and is a member of the BC franchise leadership team and the broader Oncology Business extended leadership team. This is a hybrid position requiring on-site work 2–3 days per week. The role may require up to 25% domestic and international travel. Locations listed are New York, NY, and Collegeville, PA; no relocation package is offered. The annual base salary range is $230,900–$384,800, with eligibility for a 25% target bonus under Pfizer’s Global Performance Plan and a share-based long-term incentive program. Pfizer also offers benefits including a 401(k) plan with matching and additional retirement contributions, paid vacation, holidays and personal days, paid caregiver/parental and medical leave, and medical, prescription drug, dental and vision coverage. Permanent US work authorization is required.

Requirements

  • Bachelor’s degree and 12+ years of pharmaceutical industry experience, or a master’s degree and 10+ years of pharmaceutical/biotech commercial experience.
  • US brand management experience and P&L accountability.
  • Deep understanding of US market dynamics, including specialty channels, oncology organized customers and payers.
  • Demonstrated use of AI and advanced analytics to improve customer insight, targeting, forecasting and investment decisions, and a record of championing innovative ways of working.
  • Demonstrated success developing, executing and measuring complex marketing programs and championing innovative solutions.
  • Proven ability to identify customer needs and translate insights into meaningful commercial strategies and tactics.
  • At least 5 years of direct or matrix management or coaching of marketing colleagues at Manager through Director levels.
  • Ability to influence and collaborate with peers, develop and coach others, and guide colleagues’ work to achieve meaningful outcomes and business impact.
  • Commitment to team engagement, a positive team culture and developing people.
  • Collaborative ability to engage experts across functions to improve business performance and find a path forward.
  • Strong analytical skills; detail- and action-oriented, creative, flexible and self-motivated.
  • Excellent verbal and written communication skills for a wide range of audiences, including senior executives.
  • Acts as a role model for Pfizer values.
  • Ability to work in a fast-paced environment and make complex decisions quickly.
  • Ability to synthesize and analyze complex data, understand trends and perform mathematical calculations.
  • Ability to work at a computer for extended periods using common applications such as Outlook, Excel and PowerPoint.
  • Ability to travel domestically and internationally as needed; travel may be up to 25%.
  • Permanent work authorization in the United States.

Nice To Haves

  • Oncology marketing experience.
  • Experience managing a brand through loss of exclusivity.
  • Experience leading a US oncology or specialty product launch from pre-launch market shaping through first-line commercialization.
  • Experience designing, piloting or scaling new go-to-market models, such as omnichannel or AI-enabled customer engagement, hybrid field/digital coverage or account-based approaches, and applying them through a brand lifecycle transition.
  • Experience leading patient marketing, including DTC/DTP strategy, patient support and adherence programs, and advocacy engagement, and integrating patient and HCP strategies into one customer plan.

Responsibilities

  • Own IBRANCE forecasting, operating expenses, resource allocation, P&L management and performance of marketing tactics; make revenue and expense trade-offs through loss of exclusivity and redeploy released investment against portfolio priorities.
  • Define and execute IBRANCE strategy through loss of exclusivity, including growth opportunities, the heritage campaign, and an LOE plan covering scenarios, customer and account communications, partnerships, patient marketing and generic-entry readiness.
  • Set a multi-year atirmociclib strategy and lead launch readiness for frontline metastatic breast cancer and early breast cancer indications.
  • Develop atirmociclib pricing, contracting, channel, distribution and gross-to-net strategies with Market Access, Pricing and Trade.
  • Lead US HCP and account strategy for atirmociclib, including positioning, segmentation, target customers, launch planning, disease-state education and pre-launch engagement.
  • Define launch-readiness milestones, evidence needs and the investment case with Global, Market Access, Commercial Insights and Sales.
  • Measure marketing initiatives and use advanced analytics to generate learnings and improve performance against brand objectives.
  • Ensure marketing materials are compelling, compliant and appropriate across channels, including AI-enabled and omnichannel touchpoints.
  • Gather customer insights with Medical, market analytics, AI/data science, field colleagues and prescribers, and translate them into actionable strategies.
  • Develop an integrated HR+ patient strategy and partner with enterprise patient support functions to create an end-to-end experience that removes barriers to starting and staying on therapy.
  • Lead patient marketers responsible for direct-to-patient marketing, patient support, adherence programs and advocacy strategy for IBRANCE and atirmociclib.
  • Build an operating model, metrics and feedback loops connecting field sales and marketing execution to patients and shared commercial outcomes.
  • Define how customers, accounts and field effort transition from IBRANCE to atirmociclib, including customer segments, messages and timing.
  • Align with Breast Cancer Sales and Key Account Director leadership on sales meetings, customer feedback, class growth, IBRANCE class leadership and changing field priorities.
  • Lead development of the customer insight plan and use it to anticipate HCP choices among CDK inhibitors and evolve strategy during the portfolio transition.
  • Coordinate with other franchise asset leads, including KAT6i/prifetrastat and TUKYSA, to connect patient journeys and align messages.
  • Directly lead, develop, engage and coach Director- and Senior Manager-level marketers; plan roles, development and succession as the portfolio shifts from IBRANCE to atirmociclib.
  • Foster a positive, collaborative culture across the broader US Breast Cancer marketing team and contribute to franchise and Oncology Business leadership.

Benefits

  • 401(k) plan with Pfizer matching contributions and an additional Pfizer retirement savings contribution.
  • Paid vacation, holidays and personal days.
  • Paid caregiver/parental and medical leave.
  • Medical, prescription drug, dental and vision coverage.
  • Eligible for a 25% target bonus through Pfizer’s Global Performance Plan.
  • Eligible to participate in a share-based long-term incentive program.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service